Effect of Diaphragmatic Myofascial Release on Pulmonary Function in Kyphotic Adolescents

• Sponsor: Delta University for Science and Technology (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05732090
• Collaborator: (none)
• Enrollment: 50
• Arms: 2
• Anticipated Duration (Months): 2.3

Study Details

Study Description

Brief Summary

Adolescents kyphotic girls will participated in this study. they will divided into two groups. Group A: control group will received therapeutic exercise program with pulmonary training by incentive mechanical respiratory training spirometer. Group B: study group will received the same intervention in group A in addition to diaphragmatic myofascial release. They will assessed at the baseline time and after successive two months of interventions for the following outcomes: Cobb angle by x-ray and pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Condition or Disease	Intervention/Treatment	Phase
Adolescent Kyphosis	Other: therapeutic exercise program with pulmonary training; Other: diaphragmatic myofascial release	N/A

Detailed Description

Adolescents kyphotic girls with age ranged from 13-16 years old will participated in this study. they will divided into two groups. Group A: control group will received therapeutic exercise program with pulmonary training by incentive mechanical respiratory training spirometer. Group B: study group will received the same intervention in group A in addition to diaphragmatic myofascial release. both group will received intervention for successive two months. they will assessed at the baseline time and after successive two months of interventions for the following outcomes:

Primary outcome: Cobb angle by x-ray Secondary outcome: pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 50 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Investigator)
• Primary Purpose: Treatment
• Official Title: Effect of Diaphragmatic Myofascial Release on Pulmonary Function in Kyphotic Adolescents: Randomized Control Trail
• Anticipated Study Start Date: Feb 25, 2023
• Anticipated Primary Completion Date: Apr 30, 2023
• Anticipated Study Completion Date: May 7, 2023

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Control group (A) control group will received therapeutic exercise program with pulmonary training by incentive mechanical respiratory training spirometer (3 sessions/week/two months).	Other: therapeutic exercise program with pulmonary training; therapeutic exercise program with pulmonary training (3 sessions/week/two months).
Experimental: study Group (B) study group will received the same intervention in control group in addition to diaphragmatic myofascial release (3 sessions/week/two months).	Other: therapeutic exercise program with pulmonary training; therapeutic exercise program with pulmonary training (3 sessions/week/two months).; Other: diaphragmatic myofascial release; therapeutic exercise program with pulmonary training in addition to diaphragmatic myofascial release (3 sessions/week/two months).

Outcome Measures

Primary Outcome Measures

1. Cobb angle [Change from Cobb angle at 2 months]

   Cobb angle by x-ray

Secondary Outcome Measures

1. pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) [Change from pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) at 2 months]

   pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Eligibility Criteria

Criteria

• Ages Eligible for Study: 13 Years to 16 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Adolescents girls with thoracic kyphosis with cobb angle ranged from 45 to 55 degree.

• Age ranged from 13 to 16 years old.

• selected from preparatory and secondary schools.

Exclusion Criteria:

• free from any associated deformities other than the thoracic kyphotic deformity.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Delta University for Science and Technology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Amira Hussin Hussin Mohammed, Assistant professor at faculty of physical therapy, Delta University for Science and Technology
• ClinicalTrials.gov Identifier: NCT05732090
• Other Study ID Numbers: diaphragm myofascial release
• First Posted: Feb 16, 2023
• Last Update Posted: Feb 21, 2023
• Last Verified: Feb 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Kyphosis; Scheuermann Disease; Spinal Osteochondrosis

Study Results

No Results Posted as of Feb 21, 2023